Reported Earlier, Twist Bioscience Prices Upsized Public Offering Of 3,125,000 Common Shares At $96.00 Per Share To Fund R&D And Manufacturing Expansion
Share
Why It Matters
Twist Bioscience is selling more shares of the company to raise money for research and building new factories. When a company does this, it means they need cash to grow, but it also means each piece of ownership gets a tiny bit smaller for people who already own shares.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.